By Anthony Rivas | Mon, 12/02/2013 - 15:58
Thalidomide, which was used in the 1960s to treat morning sickness, caused many children to be born with defects. Now, over 100 Australian victims recently settled a class-action suit for $81 million.
By Justin Caba | Mon, 12/02/2013 - 13:17
Researchers from the Seattle Children's Hospital have developed a brain cancer treatment using scorpion venom. They're calling it "tumor paint" due to the way it "paints" cancer cells within the brain, highlighting them for ease of targeting.
By Matthew Mientka | Sun, 12/01/2013 - 17:21
As marijuana gains popular support in America, some researchers are saying that it changes the expression of genes associated with motivation in up to three generations of offspring.
By Ajit Jha | Fri, 11/29/2013 - 09:48
A byproduct of cholesterol, called 27HC, spurs the growth and spread of breast cancer by mimicking the hormone estrogen. Researchers say that tumors can use it as a source of fuel.
By John Ericson | Wed, 11/27/2013 - 18:02
The sodium in some types of medicine may increase a patient's risk of stroke by up to 16 percent.
By Lizette Borreli | Wed, 11/27/2013 - 13:05
A new way to help people lose weight could include an implanted chip that releases a diet drug to suppress hunger and stabilize blood-fat levels.
By Susan Scutti | Tue, 11/26/2013 - 16:35
The FDA removed certain restrictions on GlaxoSmithKline's diabetes drug Avandia (rosiglitazone), which will now be available for wider use.
By Chris Weller | Tue, 11/26/2013 - 16:00
Immune-modulating drug thalidomide induced clinical remission for pediatric Crohn's disease sufferers for more than 180 weeks.